AbstractRedirecting retroviral vector transduction simply by insertion of a ligand into the envelope (Env) protein has met with several obstacles. For example, virions targeted to epidermal growth factor receptor (EGFR), after receptor binding, rapidly traffic to the lysosomes, where they are degraded. Exotoxin A of Pseudomonas aeruginosa has the ability to translocate from endosomes to the cytoplasm by means of a translocation domain (TLD). We generated a series of chimeric Env proteins of Moloney murine leukemia virus containing EGFR ligands, where TLD was inserted into different regions. These chimeric proteins were successfully produced, if the translocation domain was not located at the immediate N-terminus of Env. The ability to trans...
AbstractWe constructed alphavirus vectors encoding the ecotropic murine leukemia virus (MLV) recepto...
Successful gene therapy for breast and ovarian cancer will likely require that anti-cancer genes be ...
AbstractLibraries of feline leukemia virus subgroup A (FeLV-A)-derived envelope (Env) proteins with ...
AbstractRedirecting retroviral vector transduction simply by insertion of a ligand into the envelope...
A potential approach to in vivo gene therapy is to target retrovirus to specific receptors through a...
AbstractTargeted gene transfer into human cells has previously been achieved with spleen necrosis vi...
In the accompanying study, we show how retroviral tropism can be redirected by insertion of short pe...
A potentially powerful approach for in vivo gene delivery is to target retrovirus to specific cells ...
AbstractWe have constructed chimeric retroviral envelopes displaying N-terminal polypeptides that ar...
AbstractPreviously we have shown that it is possible to target retroviral vectors to cells using avi...
AbstractThe coreceptor usage of HIV-1 envelope proteins (Env) is mainly dependent on a defined varia...
Highly effective, targeted therapies against cancer would revolutionize the way people recover from ...
It is known that targeted infection requires the modification of the viral envelope, in order to ren...
Targeted gene transfer into human cells has previously been achieved with spleen necrosis virus (SNV...
Cancer cells have been known to overexpress the epidermal growth factor receptor (EGFR) and hence re...
AbstractWe constructed alphavirus vectors encoding the ecotropic murine leukemia virus (MLV) recepto...
Successful gene therapy for breast and ovarian cancer will likely require that anti-cancer genes be ...
AbstractLibraries of feline leukemia virus subgroup A (FeLV-A)-derived envelope (Env) proteins with ...
AbstractRedirecting retroviral vector transduction simply by insertion of a ligand into the envelope...
A potential approach to in vivo gene therapy is to target retrovirus to specific receptors through a...
AbstractTargeted gene transfer into human cells has previously been achieved with spleen necrosis vi...
In the accompanying study, we show how retroviral tropism can be redirected by insertion of short pe...
A potentially powerful approach for in vivo gene delivery is to target retrovirus to specific cells ...
AbstractWe have constructed chimeric retroviral envelopes displaying N-terminal polypeptides that ar...
AbstractPreviously we have shown that it is possible to target retroviral vectors to cells using avi...
AbstractThe coreceptor usage of HIV-1 envelope proteins (Env) is mainly dependent on a defined varia...
Highly effective, targeted therapies against cancer would revolutionize the way people recover from ...
It is known that targeted infection requires the modification of the viral envelope, in order to ren...
Targeted gene transfer into human cells has previously been achieved with spleen necrosis virus (SNV...
Cancer cells have been known to overexpress the epidermal growth factor receptor (EGFR) and hence re...
AbstractWe constructed alphavirus vectors encoding the ecotropic murine leukemia virus (MLV) recepto...
Successful gene therapy for breast and ovarian cancer will likely require that anti-cancer genes be ...
AbstractLibraries of feline leukemia virus subgroup A (FeLV-A)-derived envelope (Env) proteins with ...